Miroslaw Kozlowski

Medical University of Białystok — Poland

Medicine · Health Sciences

8h-index2.6kcitations19works0.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(12), Virus-based gene therapy research(6), RNA Interference and Gene Delivery(4), CRISPR and Genetic Engineering(4), Immune Cell Function and Interaction(4)

Publications19 total

First use of andexanet alfa in the management of massive delayed hemothorax
Turkish Journal of Emergency Medicine·2026Open Access
Evaluating the prognostic value of Wnt signaling pathways in non-small cell lung cancer patients
Advances in Medical Sciences·2025
Selective support of engineered T cells using a cis-targeted interleukin-2 enhances anti-tumor activity and obviates the need for lymphodepletion
2025Open Access
Selective Support of CAR-T Cell Therapies By Cis-Targeted IL-2 Enhances Anti-Tumor Activity and Obviates the Need for Lymphodepletion in Non-Human Primates
Blood·2024· 1 citedOpen Access
BTK Inhibition Prevents the Induction of Myeloid-Derived Suppressor Cells in Malignancy and Improves CART Function
Blood·2024· 2 citedOpen Access
Abstract PR07: Human chimeric antigen receptor (CAR) macrophages for cancer immunotherapy
Cancer Immunology Research·2020· 3 cited
Human chimeric antigen receptor macrophages for cancer immunotherapy
Nature Biotechnology·2020· 1.3k citedOpen Access
A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor–positive cells
Blood·2019· 32 citedOpen Access
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia
Cell·2018· 450 citedOpen Access
Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia
Blood·2017· 168 citedOpen Access
Engineering Resistance to Antigen-Specific Immunotherapy in Normal Hematopoietic Stem Cells By Gene Editing to Enable Targeting of Acute Myeloid Leukemia
Blood·2016· 4 cited
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
Journal of Clinical Investigation·2016· 549 citedOpen Access
273. Genome Editing Using CRISPR-Cas9 to Increase the Therapeutic Index of Antigen-Specific Immunotherapy in Acute Myeloid Leukemia
Molecular Therapy·2016· 4 citedOpen Access
Efficient Termination of CD123-Redirected Chimeric Antigen Receptor T Cells for Acute Myeloid Leukemia to Mitigate Toxicity
Blood·2015· 14 cited
Posttranslational Modification Of The Thrombopoietin Receptor Regulates Cytokine Signal Transduction and Hematopoietic Stem Cell Engraftment
Blood·2013· 1 cited
Long-term production of human factor IX protein in the breast milk of non-transgenic mice via early gestational intra-amniotic gene transfer
Journal of the American College of Surgeons·2013
Regulation of Cytokine Signal Transduction in Hematopoietic Stem Cells by Mammalian Target of Rapamycin
Blood·2012· 1 cited
High-Level Expression of Cancer/Testis Antigen NY-ESO-1 and Human Granulocyte-Macrophage Colony-Stimulating Factor in Dendritic Cells with a Bicistronic Retroviral Vector
Human Gene Therapy·2003· 16 cited
NK Lytic-Associated Molecule: A Novel Gene Selectively Expressed in Cells with Cytolytic Function
The Journal of Immunology·1999· 28 cited

Frequent Co-authors

Saar Gill(12), Marco Ruella(10), Olga Shestova(10), Saad S. Kenderian(8), Carl H. June(7), Michael Klichinsky(6), Feng Shen(6), Miriam Kim(5), Maksim Shestov(5), J. Joseph Melenhorst(3), Jennifer J.D. Morrissette(3), Stephan A. Grupp(3), Daniel M. Schreeder(3), Sara Sleiman(3), Joseph A. Fraietta(3), Jesse D. Vrecenak(3), Alan W. Flake(3), Xueqing Maggie Lu(2), Andrew Best(2), Katherine D. Cummins(2)